Trials / Terminated
TerminatedNCT01909908
ECM and Blood Components for Wound Healing
Treatment of Chronic Wounds Using Extracellular Matrix-Based Devices and the Patient's Own Blood Components
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 2 (actual)
- Sponsor
- Cook Group Incorporated · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The Extracellular Matrix (ECM) and Blood Components for Wound Healing feasibility study is a clinical trial approved by Health Canada to study the safety of extracellular matrix (ECM) and autologous blood products in wound healing.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | ECM | ECM in saline applied to wound |
| BIOLOGICAL | Blood Products | Autologous blood product applied to wound, with saline cleanse on alternating weeks |
| DEVICE | ECM in Blood Products | Alternating treatments of ECM in saline and ECM in autologous blood products, applied to wound |
Timeline
- Start date
- 2013-02-01
- Primary completion
- 2016-06-01
- Completion
- 2016-09-01
- First posted
- 2013-07-29
- Last updated
- 2016-09-29
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT01909908. Inclusion in this directory is not an endorsement.